Skip to content
ClinCalc Pro
Menu
Tetracycline antibiotic

Oxytetracycline

Brand names: Imperacin

Oxytetracycline is a tetracycline antibacterial used for infections such as acne, rosacea, respiratory and genital infections including those caused by Chlamydia.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It binds reversibly to the bacterial 30S ribosomal subunit, preventing aminoacyl-tRNA binding and inhibiting protein synthesis to give a bacteriostatic effect.

Prescribing in practice

  • It is contraindicated in pregnancy, breastfeeding and in children, as deposition in developing bone and teeth causes permanent staining and enamel defects.
  • Absorption is reduced by milk, antacids and iron, calcium, magnesium or zinc salts, which should be separated from dosing.
  • It can cause photosensitivity and should be used with caution in renal impairment, where tetracyclines may accumulate.

Monitoring

Routine monitoring is not usually required for short courses; review renal function with prolonged use or in renal impairment.

Counselling the patient

  • Take it on an empty stomach with water and avoid milk, antacids or mineral supplements around the same time.
  • Use sun protection as your skin may burn more easily.
  • Do not take it if you are or might be pregnant or breastfeeding.

Evidence & guidelines

The contraindication in pregnancy and childhood from dental and skeletal effects is well established and documented in current prescribing references.

Reference: NICE NG198 acne; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.